SCHEMBL4060866

SCHEMBL4060866

CC(C)(C)c1cc(Cc2ccc(O)cc2O)c(O)c(Cc2ccc(O)cc2O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ TYR P14679 8/20 0.47
▸ MEN1 O00255 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ CYP2C9 P11712 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ ALOX15 P16050 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GABRA1 P14867 1/20 0.41
▸ GABRB2 P47870 1/20 0.41
▸ CYP2D6 P10635 1/20 0.40
▸ NR1I2 O75469 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14462753 0.92 CYP2C19 (0.41) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL8462604 0.84 SHBG (0.50) ALOX5TYRMEN1MAPTKMT2A
SCHEMBL10445744 0.81 TYR (0.58) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL4059100 0.80 AMY1A (0.61) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL4004589 0.80 AMY1A (0.61) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL4055159 0.80 AMY1A (0.61) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL30703618 0.80 AMY1A (0.61) ALOX5CYP2C19TYRMEN1MAPT
SCHEMBL8462607 0.79 TYR (0.50) ALOX5TYRMEN1MAPTKMT2A
SCHEMBL51397 0.79 TYR (0.71) ALOX5TYRMEN1MAPTKMT2A
SCHEMBL1345705 0.79 CYP2D6 (0.59) CYP2C19MEN1MAPTKMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 — — US disclosed
EP-1132773-B1 POSITIVE-TYPE PHOTOSENSITIVE POLYIMIDE PRECURSOR COMPOSITION TORAY INDUSTRIES (JP) 2007-07-11 — — EP disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 — — EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM ALOX5 576/4885CYP2C19 1402/4885TYR 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback